Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

First 24-Hour Painkiller Available Soon To 3.2 Million Australians

This article was originally published in PharmAsia News

Executive Summary

Australians soon will have access to their first 24-hour painkiller under the country's Pharmaceutical Benefits Scheme. The government has approved coverage of Durotram XR (tramadol) made by Ortho McNeil Janssen. Pain specialists cheered the inclusion of the drug as one way to reduce dependence on morphine and oxycodone, both of which can lead to misuse. Chronic pain in Australia is estimated to affect about 3.2 million people. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC067174

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel